nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—Type IV hypersensitivity reaction—Procarbazine—brain cancer	0.114	0.128	CcSEcCtD
Mometasone—Hyperadrenocorticism—Temozolomide—brain cancer	0.056	0.0628	CcSEcCtD
Mometasone—Skin atrophy—Hydroxyurea—brain cancer	0.0367	0.0412	CcSEcCtD
Mometasone—Contusion—Lomustine—brain cancer	0.0259	0.029	CcSEcCtD
Mometasone—Fluocinonide—SMO—brain cancer	0.0229	0.907	CrCbGaD
Mometasone—Impaired healing—Carmustine—brain cancer	0.0207	0.0232	CcSEcCtD
Mometasone—Haemoptysis—Procarbazine—brain cancer	0.0194	0.0217	CcSEcCtD
Mometasone—Dysphonia—Procarbazine—brain cancer	0.0174	0.0195	CcSEcCtD
Mometasone—Oral candidiasis—Carmustine—brain cancer	0.0141	0.0158	CcSEcCtD
Mometasone—Oral candidiasis—Temozolomide—brain cancer	0.0136	0.0153	CcSEcCtD
Mometasone—Influenza-like symptoms—Temozolomide—brain cancer	0.0121	0.0136	CcSEcCtD
Mometasone—Ulcer—Hydroxyurea—brain cancer	0.0117	0.0131	CcSEcCtD
Mometasone—Otitis media—Temozolomide—brain cancer	0.0111	0.0125	CcSEcCtD
Mometasone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.0109	0.133	CbGpPWpGaD
Mometasone—Endocrine disorder—Temozolomide—brain cancer	0.0105	0.0117	CcSEcCtD
Mometasone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00984	0.12	CbGpPWpGaD
Mometasone—Viral infection—Temozolomide—brain cancer	0.00959	0.0107	CcSEcCtD
Mometasone—Infection—Carboplatin—brain cancer	0.00914	0.0102	CcSEcCtD
Mometasone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00895	0.109	CbGpPWpGaD
Mometasone—Musculoskeletal pain—Temozolomide—brain cancer	0.00877	0.00983	CcSEcCtD
Mometasone—Tingling sensation—Etoposide—brain cancer	0.00863	0.00966	CcSEcCtD
Mometasone—Candida infection—Carmustine—brain cancer	0.00856	0.00959	CcSEcCtD
Mometasone—Influenza like illness—Temozolomide—brain cancer	0.00841	0.00943	CcSEcCtD
Mometasone—Candida infection—Temozolomide—brain cancer	0.00827	0.00927	CcSEcCtD
Mometasone—Infection—Lomustine—brain cancer	0.008	0.00896	CcSEcCtD
Mometasone—Pain—Carboplatin—brain cancer	0.00787	0.00882	CcSEcCtD
Mometasone—Anorexia—Lomustine—brain cancer	0.00768	0.0086	CcSEcCtD
Mometasone—Skin discolouration—Etoposide—brain cancer	0.00768	0.0086	CcSEcCtD
Mometasone—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00763	0.0927	CbGpPWpGaD
Mometasone—Epistaxis—Procarbazine—brain cancer	0.00756	0.00847	CcSEcCtD
Mometasone—Ear pain—Temozolomide—brain cancer	0.00737	0.00826	CcSEcCtD
Mometasone—Ulcer—Etoposide—brain cancer	0.00733	0.00821	CcSEcCtD
Mometasone—Body temperature increased—Carboplatin—brain cancer	0.00728	0.00815	CcSEcCtD
Mometasone—Gastroenteritis—Temozolomide—brain cancer	0.0071	0.00795	CcSEcCtD
Mometasone—Injury—Carmustine—brain cancer	0.00708	0.00793	CcSEcCtD
Mometasone—Decreased appetite—Lomustine—brain cancer	0.007	0.00784	CcSEcCtD
Mometasone—Nasal congestion—Temozolomide—brain cancer	0.0069	0.00774	CcSEcCtD
Mometasone—Candida infection—Etoposide—brain cancer	0.00662	0.00742	CcSEcCtD
Mometasone—Body temperature increased—Lomustine—brain cancer	0.00637	0.00713	CcSEcCtD
Mometasone—NR3C1—Endoderm Differentiation—OTX2—brain cancer	0.00562	0.0684	CbGpPWpGaD
Mometasone—Cough—Procarbazine—brain cancer	0.00547	0.00613	CcSEcCtD
Mometasone—Arthralgia—Procarbazine—brain cancer	0.00533	0.00598	CcSEcCtD
Mometasone—Myalgia—Procarbazine—brain cancer	0.00533	0.00598	CcSEcCtD
Mometasone—Bronchitis—Temozolomide—brain cancer	0.00523	0.00586	CcSEcCtD
Mometasone—Dry mouth—Procarbazine—brain cancer	0.00522	0.00584	CcSEcCtD
Mometasone—Vomiting—Lomustine—brain cancer	0.00512	0.00574	CcSEcCtD
Mometasone—Infection—Procarbazine—brain cancer	0.00508	0.00569	CcSEcCtD
Mometasone—Upper respiratory tract infection—Temozolomide—brain cancer	0.00505	0.00566	CcSEcCtD
Mometasone—Urinary tract infection—Carmustine—brain cancer	0.00488	0.00546	CcSEcCtD
Mometasone—Anorexia—Procarbazine—brain cancer	0.00487	0.00546	CcSEcCtD
Mometasone—Nausea—Lomustine—brain cancer	0.00478	0.00536	CcSEcCtD
Mometasone—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.00473	0.0575	CbGpPWpGaD
Mometasone—Urinary tract infection—Temozolomide—brain cancer	0.00471	0.00528	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00466	0.00522	CcSEcCtD
Mometasone—Paraesthesia—Procarbazine—brain cancer	0.00459	0.00514	CcSEcCtD
Mometasone—Sinusitis—Temozolomide—brain cancer	0.00455	0.0051	CcSEcCtD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.00455	0.0553	CbGpPWpGaD
Mometasone—Decreased appetite—Procarbazine—brain cancer	0.00444	0.00498	CcSEcCtD
Mometasone—Fatigue—Procarbazine—brain cancer	0.00441	0.00494	CcSEcCtD
Mometasone—Pain—Procarbazine—brain cancer	0.00437	0.0049	CcSEcCtD
Mometasone—Pharyngitis—Temozolomide—brain cancer	0.00432	0.00484	CcSEcCtD
Mometasone—Bronchospasm—Etoposide—brain cancer	0.00428	0.00479	CcSEcCtD
Mometasone—Gastrointestinal pain—Procarbazine—brain cancer	0.00418	0.00468	CcSEcCtD
Mometasone—Abdominal pain—Procarbazine—brain cancer	0.00404	0.00453	CcSEcCtD
Mometasone—Body temperature increased—Procarbazine—brain cancer	0.00404	0.00453	CcSEcCtD
Mometasone—Infection—Hydroxyurea—brain cancer	0.00393	0.0044	CcSEcCtD
Mometasone—Immune system disorder—Temozolomide—brain cancer	0.00393	0.0044	CcSEcCtD
Mometasone—Mediastinal disorder—Temozolomide—brain cancer	0.00392	0.00439	CcSEcCtD
Mometasone—Back pain—Carmustine—brain cancer	0.00379	0.00425	CcSEcCtD
Mometasone—Anorexia—Hydroxyurea—brain cancer	0.00377	0.00423	CcSEcCtD
Mometasone—Asthenia—Procarbazine—brain cancer	0.00367	0.00411	CcSEcCtD
Mometasone—Back pain—Temozolomide—brain cancer	0.00366	0.00411	CcSEcCtD
Mometasone—Pruritus—Procarbazine—brain cancer	0.00362	0.00405	CcSEcCtD
Mometasone—Dyspnoea—Hydroxyurea—brain cancer	0.00353	0.00395	CcSEcCtD
Mometasone—Diarrhoea—Procarbazine—brain cancer	0.0035	0.00392	CcSEcCtD
Mometasone—Dyspepsia—Hydroxyurea—brain cancer	0.00348	0.0039	CcSEcCtD
Mometasone—Angioedema—Temozolomide—brain cancer	0.00346	0.00388	CcSEcCtD
Mometasone—Decreased appetite—Hydroxyurea—brain cancer	0.00344	0.00385	CcSEcCtD
Mometasone—Fatigue—Hydroxyurea—brain cancer	0.00341	0.00382	CcSEcCtD
Mometasone—Pain—Hydroxyurea—brain cancer	0.00338	0.00379	CcSEcCtD
Mometasone—Myalgia—Carmustine—brain cancer	0.00334	0.00374	CcSEcCtD
Mometasone—Chest pain—Carmustine—brain cancer	0.00334	0.00374	CcSEcCtD
Mometasone—Cough—Temozolomide—brain cancer	0.00331	0.0037	CcSEcCtD
Mometasone—Vomiting—Procarbazine—brain cancer	0.00325	0.00364	CcSEcCtD
Mometasone—Myalgia—Temozolomide—brain cancer	0.00322	0.00361	CcSEcCtD
Mometasone—Arthralgia—Temozolomide—brain cancer	0.00322	0.00361	CcSEcCtD
Mometasone—Rash—Procarbazine—brain cancer	0.00322	0.00361	CcSEcCtD
Mometasone—Dermatitis—Procarbazine—brain cancer	0.00322	0.00361	CcSEcCtD
Mometasone—Headache—Procarbazine—brain cancer	0.0032	0.00359	CcSEcCtD
Mometasone—Infection—Carmustine—brain cancer	0.00318	0.00356	CcSEcCtD
Mometasone—Dry mouth—Temozolomide—brain cancer	0.00315	0.00353	CcSEcCtD
Mometasone—Immune system disorder—Etoposide—brain cancer	0.00314	0.00352	CcSEcCtD
Mometasone—Mediastinal disorder—Etoposide—brain cancer	0.00314	0.00352	CcSEcCtD
Mometasone—Body temperature increased—Hydroxyurea—brain cancer	0.00313	0.0035	CcSEcCtD
Mometasone—Anaphylactic shock—Temozolomide—brain cancer	0.00309	0.00346	CcSEcCtD
Mometasone—Infection—Temozolomide—brain cancer	0.00307	0.00344	CcSEcCtD
Mometasone—Anorexia—Carmustine—brain cancer	0.00305	0.00342	CcSEcCtD
Mometasone—Nausea—Procarbazine—brain cancer	0.00304	0.0034	CcSEcCtD
Mometasone—Anorexia—Temozolomide—brain cancer	0.00295	0.0033	CcSEcCtD
Mometasone—Back pain—Etoposide—brain cancer	0.00293	0.00328	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Carmustine—brain cancer	0.00291	0.00327	CcSEcCtD
Mometasone—Paraesthesia—Carmustine—brain cancer	0.00287	0.00322	CcSEcCtD
Mometasone—Dyspnoea—Carmustine—brain cancer	0.00285	0.0032	CcSEcCtD
Mometasone—Asthenia—Hydroxyurea—brain cancer	0.00284	0.00318	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00282	0.00316	CcSEcCtD
Mometasone—Decreased appetite—Carmustine—brain cancer	0.00278	0.00312	CcSEcCtD
Mometasone—Paraesthesia—Temozolomide—brain cancer	0.00278	0.00311	CcSEcCtD
Mometasone—Dyspnoea—Temozolomide—brain cancer	0.00276	0.00309	CcSEcCtD
Mometasone—Pain—Carmustine—brain cancer	0.00274	0.00306	CcSEcCtD
Mometasone—Dyspepsia—Temozolomide—brain cancer	0.00272	0.00305	CcSEcCtD
Mometasone—Diarrhoea—Hydroxyurea—brain cancer	0.00271	0.00303	CcSEcCtD
Mometasone—Decreased appetite—Temozolomide—brain cancer	0.00269	0.00301	CcSEcCtD
Mometasone—Fatigue—Temozolomide—brain cancer	0.00267	0.00299	CcSEcCtD
Mometasone—Cough—Etoposide—brain cancer	0.00264	0.00296	CcSEcCtD
Mometasone—Pain—Temozolomide—brain cancer	0.00264	0.00296	CcSEcCtD
Mometasone—Gastrointestinal pain—Carmustine—brain cancer	0.00262	0.00293	CcSEcCtD
Mometasone—Chest pain—Etoposide—brain cancer	0.00258	0.00289	CcSEcCtD
Mometasone—Abdominal pain—Carmustine—brain cancer	0.00253	0.00283	CcSEcCtD
Mometasone—Body temperature increased—Carmustine—brain cancer	0.00253	0.00283	CcSEcCtD
Mometasone—Gastrointestinal pain—Temozolomide—brain cancer	0.00253	0.00283	CcSEcCtD
Mometasone—Vomiting—Hydroxyurea—brain cancer	0.00252	0.00282	CcSEcCtD
Mometasone—Rash—Hydroxyurea—brain cancer	0.00249	0.0028	CcSEcCtD
Mometasone—Dermatitis—Hydroxyurea—brain cancer	0.00249	0.00279	CcSEcCtD
Mometasone—Headache—Hydroxyurea—brain cancer	0.00248	0.00278	CcSEcCtD
Mometasone—Anaphylactic shock—Etoposide—brain cancer	0.00247	0.00277	CcSEcCtD
Mometasone—Infection—Etoposide—brain cancer	0.00246	0.00275	CcSEcCtD
Mometasone—Body temperature increased—Temozolomide—brain cancer	0.00244	0.00274	CcSEcCtD
Mometasone—Abdominal pain—Temozolomide—brain cancer	0.00244	0.00274	CcSEcCtD
Mometasone—Dexamethasone—CYP2C9—brain cancer	0.00236	0.0935	CrCbGaD
Mometasone—Anorexia—Etoposide—brain cancer	0.00236	0.00264	CcSEcCtD
Mometasone—Nausea—Hydroxyurea—brain cancer	0.00235	0.00263	CcSEcCtD
Mometasone—Asthenia—Carmustine—brain cancer	0.0023	0.00257	CcSEcCtD
Mometasone—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00227	0.0276	CbGpPWpGaD
Mometasone—Paraesthesia—Etoposide—brain cancer	0.00222	0.00249	CcSEcCtD
Mometasone—Asthenia—Temozolomide—brain cancer	0.00222	0.00249	CcSEcCtD
Mometasone—Dyspnoea—Etoposide—brain cancer	0.00221	0.00247	CcSEcCtD
Mometasone—Diarrhoea—Carmustine—brain cancer	0.00219	0.00245	CcSEcCtD
Mometasone—Pruritus—Temozolomide—brain cancer	0.00219	0.00245	CcSEcCtD
Mometasone—Decreased appetite—Etoposide—brain cancer	0.00215	0.00241	CcSEcCtD
Mometasone—Fatigue—Etoposide—brain cancer	0.00213	0.00239	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.00213	0.0259	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—ESR2—brain cancer	0.00212	0.0258	CbGpPWpGaD
Mometasone—Pain—Etoposide—brain cancer	0.00212	0.00237	CcSEcCtD
Mometasone—Diarrhoea—Temozolomide—brain cancer	0.00212	0.00237	CcSEcCtD
Mometasone—Vomiting—Carmustine—brain cancer	0.00203	0.00228	CcSEcCtD
Mometasone—Gastrointestinal pain—Etoposide—brain cancer	0.00202	0.00227	CcSEcCtD
Mometasone—Rash—Carmustine—brain cancer	0.00202	0.00226	CcSEcCtD
Mometasone—Dermatitis—Carmustine—brain cancer	0.00202	0.00226	CcSEcCtD
Mometasone—Headache—Carmustine—brain cancer	0.002	0.00225	CcSEcCtD
Mometasone—Vomiting—Temozolomide—brain cancer	0.00197	0.0022	CcSEcCtD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00196	0.0239	CbGpPWpGaD
Mometasone—Body temperature increased—Etoposide—brain cancer	0.00196	0.00219	CcSEcCtD
Mometasone—Abdominal pain—Etoposide—brain cancer	0.00196	0.00219	CcSEcCtD
Mometasone—Rash—Temozolomide—brain cancer	0.00195	0.00218	CcSEcCtD
Mometasone—Dermatitis—Temozolomide—brain cancer	0.00195	0.00218	CcSEcCtD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00194	0.0235	CbGpPWpGaD
Mometasone—Headache—Temozolomide—brain cancer	0.00194	0.00217	CcSEcCtD
Mometasone—Nausea—Carmustine—brain cancer	0.0019	0.00213	CcSEcCtD
Mometasone—Nausea—Temozolomide—brain cancer	0.00184	0.00206	CcSEcCtD
Mometasone—Asthenia—Etoposide—brain cancer	0.00177	0.00199	CcSEcCtD
Mometasone—Pruritus—Etoposide—brain cancer	0.00175	0.00196	CcSEcCtD
Mometasone—Diarrhoea—Etoposide—brain cancer	0.00169	0.0019	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00168	0.0204	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HES5—brain cancer	0.00161	0.0196	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00159	0.0193	CbGpPWpGaD
Mometasone—Vomiting—Etoposide—brain cancer	0.00157	0.00176	CcSEcCtD
Mometasone—Rash—Etoposide—brain cancer	0.00156	0.00175	CcSEcCtD
Mometasone—Dermatitis—Etoposide—brain cancer	0.00156	0.00175	CcSEcCtD
Mometasone—Headache—Etoposide—brain cancer	0.00155	0.00174	CcSEcCtD
Mometasone—Nausea—Etoposide—brain cancer	0.00147	0.00165	CcSEcCtD
Mometasone—NR3C1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.00131	0.0159	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000845	0.0103	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000834	0.0101	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—APC—brain cancer	0.000763	0.00928	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000705	0.00857	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000685	0.00833	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000606	0.00736	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000532	0.00647	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.000525	0.00638	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000519	0.00631	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IRS2—brain cancer	0.000515	0.00626	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.000514	0.00624	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	0.000512	0.00622	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000507	0.00616	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000463	0.00562	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MYC—brain cancer	0.00041	0.00499	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000365	0.00444	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TP53—brain cancer	0.000337	0.0041	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000325	0.00395	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CTNNB1—brain cancer	0.000309	0.00375	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	0.000297	0.00361	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	0.00029	0.00352	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	0.000274	0.00333	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—STAT3—brain cancer	0.000269	0.00327	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000267	0.00324	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000237	0.00288	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000235	0.00286	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—DNMT1—brain cancer	0.000155	0.00189	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2C9—brain cancer	0.000145	0.00176	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ESR2—brain cancer	0.000139	0.00169	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NOTCH2—brain cancer	0.000132	0.00161	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—BSG—brain cancer	0.000123	0.00149	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SIRT1—brain cancer	0.000112	0.00136	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—IDH1—brain cancer	0.000106	0.00128	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—MYC—brain cancer	9.13e-05	0.00111	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.6e-05	0.00105	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ENO2—brain cancer	8.35e-05	0.00102	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MYC—brain cancer	4.4e-05	0.000535	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CG—brain cancer	3.83e-05	0.000466	CbGpPWpGaD
